ENTAENANTA PHARMACEUTICALS INC同业对比
ENANTA PHARMACEUTICALS INC 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTA本股 | $311M#7 | — | 3.1x#9 | 4.8x#4 | -3.4%#5 | 29.4%#2 | -130.7%#3 | -81.0%#10 | — | — | — | — |
| ALT | $402M#1 | — | 0.8x#2 | 9797.1x#8 | 105.0%#2 | 7.3%#5 | -230461.0%#8 | -18.6%#3 | -21.1%#3 | — | — | — |
| BLSM | $400M#2 | — | — | — | — | — | — | — | — | — | — | — |
| RZLT | $390M#3 | — | 3.9x#10 | — | — | -4.3%#7 | — | -77.1%#8 | -87.3%#4 | — | — | — |
| AVTX | $386M#4 | — | 0.9x#3 | 6535.6x#7 | -86.6%#8 | -122.8%#11 | -123601.7%#7 | -17.4%#2 | -19.3%#2 | — | — | — |
| AVIR | $342M#5 | — | 1.7x#7 | 1.0x#2 | 622.5%#1 | 6.0%#6 | -51.5%#2 | -77.4%#9 | — | — | 31.4%#1 | — |
| IRD | $328M#6 | — | — | 23.1x#5 | 29.1%#4 | 13.8%#4 | -271.9%#5 | — | — | — | — | — |
| EBS | $310M#8 | — | 1.0x#5 | 0.4x#1 | -28.8%#7 | 127.6%#1 | 13.5%#1 | 16.8%#1 | 9.9%#1 | 7#1 | -42.6%#2 | — |
| VOGX | $307M#9 | — | — | — | — | — | — | — | — | — | — | — |
| PRLD | $307M#10 | — | 2.3x#8 | 25.3x#6 | 73.4%#3 | 21.8%#3 | -861.3%#6 | -74.4%#7 | — | — | — | — |
| SPRY | $299M#11 | — | 23.9x#11 | 3.5x#3 | -5.5%#6 | -2241.8%#13 | -212.9%#4 | -1369.1%#12 | -177.6%#5 | — | — | — |
| BNTC | $296M#12 | — | 1.7x#6 | — | -100.0%#9 | -20.6%#8 | — | -25.8%#5 | — | — | — | — |
| MPLT | $292M#13 | 0.1x#1 | 0.8x#1 | — | — | -107.7%#10 | — | -46.3%#6 | — | — | — | — |
| TTRX | $291M#14 | — | 423.9x#12 | — | — | -80.6%#9 | — | -465.0%#11 | — | — | — | — |
| FULC | $286M#15 | — | 0.9x#4 | — | -100.0%#9 | -670.0%#12 | — | -24.1%#4 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议